Shanghai Pharmaceuticals Holding Co., Ltd is principally engaged in the manufacture and sale of pharmaceuticals.
Quote | Shanghai Pharms Hl H Ord (OTCMKTS:SHPMF)
Last: | $1.485 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $1.485 |
High: | $0 |
Low: | $0 |
Volume: | 61 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Shanghai Pharms Hl H Ord (OTCMKTS:SHPMF)
2023-09-17 08:35:00 ET Summary Shanghai Hasten Biopharma has entered a $325 million agreement for greater China rights to a PCSK9 inhibitor from LIB Therapeutics. Insilico Medicine has out-licensed global rights to a small molecule inhibitor to Exelixis for BRCA-mutated tumors. ...
Summary Sichuan Kelun-Biotech will partner seven preclinical antibody-drug conjugate assets with Merck in a deal that pays Kelun-Biotech $175 million upfront and up to $9.3 billion in milestones - the third ADC deal between the two companies this year. LianBio announced that Pfizer will...
Message Board Posts | Shanghai Pharms Hl H Ord (OTCMKTS:SHPMF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |